Watch to learn how recent improvements in technology are expanding capabilities across the globe. Tune in toBloomberg TV to watch a new episode of Advancements with Ted Danson on Saturday, November 15th at 8:00 PM ET. https://mma.prnewswire.com/media/2816105/Advancements_airing_on_November_15.jpg Concrete is the world's most used man-made material, with estimates of 30 billion tons produced globally each year.Advancements […]
Origin Agritech Ltd. (NASDAQ: SEED) (the “Company” or “Origin”), a leading Chinese agricultural technology company, today announced it has entered into a patent license agreement with Shandong Shunfeng Biotechnology Co., Ltd. (“Shunfeng BioTech”) for the Cas-SF01 gene editing tool. This collaboration grants Origin long-term access to fully IP-protected gene editing technologies, providing a solid foundation
Eventus, a leading provider of comprehensive, at-scale trade surveillance and financial risk solutions, has for the second consecutive year won two awards in the Regulation Asia Awards for Excellence 2025. The firm's Validus platform was again named Best Market, Trade or Communications Surveillance Solution as well as Best Digital Asset Surveillance Solution. https://mma.prnewswire.com/media/635481/Eventus_Logo.jpg Naveen Wahi,
Delivers Third Quarter Net Sales of $753.1 Million, Driven by Acthar® Gel (repository corticotropin injection) Growth and the Inclusion of Two Months of Endo Product Net Sales Expects Fourth Quarter 2025 Net Sales of $485 Million to $505 Million and Adjusted EBITDAof $155 Million to $165 Million for Keenova Raises Full-Year Acthar Gel Net Sales
Beasley Broadcast Group, Inc. (Nasdaq: BBGI) (“Beasley” or the “Company”), a multi-platform media company, today announced operating results for the three-month period ended September 30, 2025. For further information, the Company has posted a presentation to its website regarding the third quarter highlights and accomplishments that management will review on today's conference call. https://mma.prnewswire.com/media/2641491/Beasley_Media_Group_Logo.jpg Third
Canada's small and craft alcohol producers still face major roadblocks when trying to sell alcohol across provincial borders despite recent agreements meant to ease trade restrictions, finds a new report from the Canadian Federation of Independent Business (CFIB). The report, Bottled Up: Barriers facing small business in interprovincial alcohol trade, reveals that outdated rules and
(CNSX:MAXX),(CNSX:MAXX.CN),(Pinksheets:MAXXF),(PinkSheets:MAXXF),(Boerse Frankfurt – Freiverkehr:89N.F),(Boerse Frankfurt – Freiverkehr:89N), PTRC, University of Regina, Saskatchewan Geological Survey, Colorado School of Mines and the MAX Power Team Convene in Regina to Advance Natural Hydrogen Research and Visit Canada's First Active Drill Site at Lawson Watch the Drill in Action – New Video Capturing the Historic Start of Drillingat Lawson
(NYSE:APO), From left to right: Miguel Angel Gil, Enrique Cerezo, Robert Givone MADRID and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) — Atletico de Madrid and its major shareholders – Miguel Angel Gil, Enrique Cerezo, Quantum Pacific Group and Ares Management funds – have reached an agreement for Apollo Sports Capital ('ASC'), the global sports
(NASDAQ:CGEM), CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company accelerating potential high-impact therapies in autoimmune diseases and cancer, today announced its management team will participate in two upcoming investor conferences and will host a company event at the 2025 American Society of Hematology (“ASH”) Annual Meeting
(NASDAQ:IMVT), Study in uncontrolled Graves' disease (GD) patients treated for 24 weeks showed first-ever potentially disease-modifying outcome with six-month off-treatment data IMVT-1402 development is progressing with potentially registrational studies in GD, myasthenia gravis (MG), chronic inflammatory demyelinating polyneuropathy (CIDP), difficult-to-treat rheumatoid arthritis (D2T RA) and Sjogren's disease (SjD) remains on track Immunovant remains on track